STUDY OF THE INTERACTION OF THE TRANSLUTAMINASINASE 2 WITH THE TRANSCRIPTION FACTOR P73 IN THE CONTEXT OF TUMOR FORMATION

Authors: Gnennaya Y.A¹, Piacentini M.², Barlev N.A¹
Affiliations:
1. Institute of Cytology RAS
2. University of Rome “Tor Vergata"
Issue: Vol 15, No 3S (2020)
Pages: 86-86
Section: Articles
URL: https://genescells.ru/2313-1829/article/view/122794
DOI: https://doi.org/10.23868/gc122794
ID: 122794

Cite item

Full Text

Open Access
Restricted Access

Access granted
Restricted Access

Subscription or Fee Access

Institute of Cytology RAS

Email: gnennaya1996@mail.ru
Saint-Petersburg, Russia

University of Rome “Tor Vergata"

Rome, Italy

Institute of Cytology RAS

Saint-Petersburg, Russia

Nezir A. E., Ulukan, B., Telci, D. Transglutaminase 2: The Maestro of the Oncogenic Mediators in Renal Cell Carcinoma. Medical Sciences. 2019; 7(2): 24;
Tucholski, J. TG2 protects neuroblastoma cells against DNA-damage-induced stress, suppresses p53 activation. Amino Acids. 2010; 39(2): 523-532.

Supplementary Files

Action

1. JATS XML